How to Swab for MRSA: The Procedure and What to Expect

An MRSA swab is a quick, painless sample collection that usually takes less than a minute and requires no special preparation on your part. A healthcare worker (or sometimes you yourself) rotates a soft-tipped swab inside each nostril, and that sample goes to a lab for analysis. The test determines whether methicillin-resistant Staphylococcus aureus is living on your body without causing symptoms, a state known as colonization. While the nose is the most commonly swabbed site, there is growing evidence that sampling additional areas gives a far more complete picture, and the type of lab test used affects both how fast you get results and how reliable they are.

The Nasal Swab Itself

The standard MRSA screening swab targets the anterior nares, the area just inside the tip of your nose. The person collecting the sample inserts a sterile swab roughly one to two centimeters into one nostril and rotates it gently against the inner wall for about five seconds, then repeats in the other nostril with the same swab. Some facilities use a nylon flocked swab, which looks like a tiny bottle brush and is designed to pick up more bacteria than a traditional cotton-tipped swab. The sensation is mildly uncomfortable, similar to having a tickle deep in your nose, and some people sneeze. There is no pain, no numbing agent needed, and no aftereffects.

You do not need to stop any medications beforehand, though it is worth knowing that if you are already on antibiotics active against staphylococcal bacteria, the swab can still be processed. A study comparing paired nasal swabs found that the agreement between PCR and culture remained above 90% whether or not patients were receiving anti-staphylococcal antibiotics, though the molecular test was somewhat more likely to stay positive during treatment.¹ That matters because if you are screened while already taking antibiotics, a negative culture does not necessarily mean you are not carrying the organism.

Why the Nose Is Not Enough

The nose is the go-to screening site because MRSA preferentially colonizes the moist lining of the nostrils. But sampling the nose alone catches a surprisingly incomplete slice of carriers. One study found that a nasal swab alone detected only about half of colonized patients.² Adding a groin swab pushed detection up to around 79% by culture, and combining nose, groin, and throat swabs raised it to 96%. A separate investigation reported a similar pattern, with nasal swabs alone picking up roughly 51% of carriers, while adding pharyngeal and nasal swabs together brought that to about 73%.³

The groin and throat swabs are collected in a straightforward way. For the groin, the swab is rubbed across the skin of the inguinal crease (the fold where your thigh meets your torso). For the throat, the swab is touched to the back of your throat and tonsils, much like a strep-throat test. Neither is particularly uncomfortable, though the throat swab can trigger a brief gag reflex.

In some hospital protocols, all three swabs are pooled into a single transport tube. Research on pooling nose, groin, and throat specimens into one PCR assay showed that accuracy stayed high, with a sensitivity of about 78% and specificity of 99%, while cutting lab costs compared to running separate tests for each site.⁴ So if a nurse swabs your nose, groin, and throat and drops all three swabs in one tube, that is an intentional efficiency measure, not a mistake.

Other sites can also be swabbed depending on the clinical situation. Wounds, surgical incision sites, catheter exit sites, the axillae (armpits), and the perineum are all places MRSA can hide. If you have a skin breakdown or a chronic wound, the healthcare team may swab that area in addition to (or instead of) the standard screening sites.

Can You Swab Yourself?

Self-collected nasal swabs are increasingly used in outpatient settings, community surveillance, and decolonization follow-up. The natural concern is that a patient would not collect as good a sample as a trained nurse, but the data suggest otherwise. In a direct comparison, self-taken nasal swabs detected MRSA carriage at a rate that was statistically indistinguishable from nurse-taken swabs, with no significant difference between the two.⁵ Self-swabbing also predicted persistent nasal carriage over a four-week window just as well as a professional collection. If you are given a swab kit to use at home or in a clinic waiting room, follow the instructions on rotation time and depth, and the result should be reliable.

What Happens in the Lab

Once your swab reaches the laboratory, it is processed by one of two main approaches: traditional culture on specialized agar plates, or a molecular test that detects MRSA DNA directly.

Culture involves spreading the sample onto chromogenic agar, a medium that changes color in the presence of MRSA colonies. This method is cheap and widely available, but it takes time. Culture-negative results typically come back in about 30 hours, while a positive result can take close to 70 hours because suspicious colonies need additional confirmation steps.⁶ In that same evaluation, PCR-negative results were available in a mean of about six hours and positives in under seven hours, a dramatic speed advantage.

A large meta-analysis confirmed the general trade-off between the two methods. PCR tests had a pooled sensitivity of about 93%, versus roughly 78% for chromogenic media read at a single day and 88% when culture plates were read again at 48 hours. Specificity ran slightly higher for overnight culture (about 99%) than for PCR (about 97%).⁷ In practical terms, PCR is faster and catches a few more true positives, but it also occasionally flags someone who is not actually carrying viable MRSA, perhaps because it picks up residual DNA from organisms that are already dead. Culture is slower but very specific when positive.

Your hospital may use either method, and some use both: a rapid PCR for same-day clinical decisions (like whether to start certain antibiotics) and a follow-up culture for confirmation.

Understanding Your Results

A negative nasal swab is genuinely reassuring for ruling out MRSA colonization. In critically ill pediatric patients, one study found a negative predictive value of 99.8%, meaning a negative result almost certainly means the patient is not carrying invasive MRSA.⁸ Similar figures have been reported in adults. This high “rule-out” power is why many hospitals use a negative nasal swab to safely narrow antibiotic choices, stopping drugs like vancomycin earlier when they are not needed.

A positive result is harder to interpret. The same pediatric study found the positive predictive value for invasive infection was only about 9%. In a separate study of hospital patients, nasal swab screening had a positive predictive value of around 30% when compared to subsequent culture results.⁹ A positive swab means the bacteria are present on your body, but it does not mean you have or will develop an MRSA infection. Colonization and infection are different things. Many people carry MRSA without ever getting sick from it.

If your swab comes back positive, the clinical team will weigh the result alongside your symptoms, your risk factors, and the reason you were screened. A positive screen before elective surgery, for example, typically triggers a decolonization regimen rather than any invasive treatment.

When and Why MRSA Screening Happens

Hospitals screen for MRSA for two main reasons: to protect the individual patient and to protect everyone else on the ward. The most common screening triggers include admission to an intensive care unit, a planned surgical procedure (especially orthopedic or cardiac), transfer from another healthcare facility, a history of prior MRSA infection, and outbreaks on a unit.

Whether hospitals should screen every single admission or focus on high-risk patients has been debated for years. A study comparing universal versus targeted screening found that universal screening did increase MRSA detection by about three percentage points, but the resulting reduction in hospital-acquired MRSA infections was small. Economically, the program returned only about fifty cents for every dollar spent.¹⁰ Cost-effectiveness analyses from surgical settings have reached a similar conclusion: whether universal screening pays for itself depends heavily on the local MRSA prevalence. In settings where colonization rates are high, universal screening can be cost-saving; where rates are low, targeted screening of high-risk patients makes more financial sense.¹¹

A large trial across dozens of ICUs took the question further by comparing three strategies: screening plus isolation of carriers, screening plus targeted decolonization of carriers, and universal decolonization of all patients regardless of screening status. Universal decolonization reduced MRSA clinical isolates by about 37% and cut bloodstream infections from any pathogen by 44%, outperforming both approaches that relied on screening alone.¹² That finding shifted many ICUs toward a “decolonize everyone” model, reducing the need for individual screening swabs in those units.

What Happens After a Positive Screen

If you test positive for MRSA colonization before a surgery or during a hospital stay, the standard response is a decolonization protocol. The typical regimen involves applying mupirocin ointment inside your nostrils twice a day for five days and washing your body with chlorhexidine antiseptic soap or wipes during the same period. Some protocols add chlorhexidine mouthwash. The goal is to reduce or eliminate the MRSA on your skin and mucous membranes so it cannot cause an infection during a vulnerable period like surgery.

A large randomized trial studied a twice-monthly decolonization regimen of chlorhexidine baths, chlorhexidine mouthwash, and nasal mupirocin over six months in MRSA carriers discharged from hospitals. The decolonization group had about 30% fewer MRSA infections than a control group that received education alone, and participants who stuck closely to the regimen had 44% fewer MRSA infections.¹³ Side effects were mild and occurred in a small fraction of participants.

Clearing MRSA permanently is trickier. One trial comparing standard decolonization (mupirocin plus chlorhexidine) with a more aggressive approach that added oral antibiotics found that initial clearance rates were higher with the systemic approach (about 79% versus 52%), but the difference faded over time, and long-term eradication remained elusive for many patients in both groups.¹⁴ MRSA can re-colonize from your own deeper reservoirs or from the environment, which is why some people test positive again weeks or months after clearance.

Screening in Newborns

Neonatal intensive care units have their own screening rhythms. Premature and low-birth-weight infants are particularly vulnerable to MRSA, and outbreaks on neonatal units can be devastating. Weekly nasal swabs are a common surveillance strategy, but research in one NICU found that about 80% of colonized infants were first detected on nose swabs or a combination of nose and groin swabs, while groin-only positives accounted for roughly 19% and tended to be larger, more mature babies who were discharged quickly.¹⁵ That study concluded that weekly nasal swabs combined with swabbing any suspected infection sites would catch about 85% of colonized infants on the unit.

For parents, the practical takeaway is that if your baby is in a NICU and a nurse takes a small swab from the baby’s nostril once a week, it is a standard infection-control measure. The swab is tiny, the procedure is fast, and early detection allows decolonization and isolation steps that protect both your child and the other vulnerable infants nearby.

Healthcare Worker Screening

Healthcare workers are sometimes screened for MRSA, but this is not routine. Staff screening is typically triggered by a recognized outbreak on a unit, especially when patient-to-patient transmission continues despite standard control measures. The logic is that a colonized healthcare worker could be a silent link in the chain of transmission. One review noted that while screening healthcare workers during outbreaks can be valuable for determining the full extent of colonization and guiding work exclusions, routine screening of staff outside outbreak settings is not recommended because of the high rate of transient carriage, the disruption it causes, and the stigma it can create.¹⁶

When healthcare workers are screened and found positive, decolonization treatment is offered following the same mupirocin-and-chlorhexidine protocols used for patients.¹⁷ In outbreak scenarios involving particularly virulent strains, identifying and decolonizing even one colonized staff member can break the chain of transmission on a ward.

Risk Factors That Affect Who Gets Screened

MRSA was once thought of as strictly a hospital problem, but community-associated strains have blurred that boundary. One study of predominantly university-age adults in an outpatient setting found that older age and dog ownership were associated with carrying community-associated MRSA, while living in a single-family home was protective.¹⁸ The distinction between hospital-acquired and community-acquired strains has become less clear-cut in recent years, with strains that originated in the community now circulating inside hospitals and vice versa.¹⁹

Beyond hospital exposure, other known risk factors for colonization include recent antibiotic use, chronic skin conditions, living in crowded settings like dormitories or military barracks, injection drug use, and contact sports where skin-to-skin contact is frequent. If you carry any of these risk factors and are admitted to a hospital, you are more likely to be flagged for screening even in a targeted program.

The Emotional Side of Being Swabbed and Tested

Getting swabbed for MRSA can feel alarming, especially if you did not expect it. In many hospitals, screening is presented matter-of-factly on admission, but patients sometimes interpret it as a sign that they are already sick or dangerous. Worth knowing: the vast majority of MRSA screens come back negative, and even a positive result usually means colonization rather than active infection.

That said, testing positive does carry real psychological weight. A study of older adults found that MRSA-positive patients who were placed in isolation had significantly higher levels of depressive and anxious symptoms compared to both MRSA-negative patients and estimates for community-dwelling older adults.²⁰ The isolation itself, being in a single room, having visitors gown up, seeing staff put on gloves before touching you, appears to contribute to low mood beyond whatever effect the hospitalization alone has. If you or a family member is isolated for MRSA, understanding that the precautions are about preventing spread rather than about personal risk can help take some of the sting out. Asking the nursing team how long isolation is expected to last and what steps are being taken toward decolonization can also reduce the feeling of being in limbo.